Patient info Open main menu

Toussistop Cold Relief oral solution – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Patient leaflet - Toussistop Cold Relief oral solution

1. What Toussistop Cold Relief oral solution is and what it is used for

Toussistop Cold Relief oral solution contains marshmallow root, lime flower and ribwort plantain extracts.

Toussistop Cold Relief oral solution is a traditional herbal medicinal product used for relief of symptoms of the common cold such as chills, sore throat and cough, based on traditional use only.

The product is a traditional herbal medicinal product for use in the specified indications exclusively based upon long-standing use.

You must talk to a doctor if you feel worse or if you do not feel better after 7 days.

2. What you need to know before you take Toussistop Cold Relief oral solution

Do not take Toussistop Cold Relief oral solution

  • if you are allergic to marshmallow root, lime flower, ribwort plantain, ribwort plantain pollen or any of the other ingredients of this medicine (listed in section 6)
  • if you are pregnant or breast-feeding
  • if you are under 12 years old

Warnings and precautions

Talk to your doctor or pharmacist if while taking Toussistop Cold Relief oral solution:

  • you do not feel better or if you feel worse
  • you are short of breath (dyspnoea)
  • you have a high temperature (fever)
  • your phlegm is yellow-green or brown in color (purulent sputum)

If the symptoms worsen or if adverse effect not mentioned in the package leaflet occurs during the use of the medicinal product, a doctor or pharmacist should be consulted.

This medicine may delay the absorption of other medicines taken at the same time.

Other medicines and Toussistop Cold Relief oral solution

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines before taking this medicine.

It is not known if this medicine may affect the actions of other medicines. It may delay the absorption of other medicines taken at the same time. As a precautionary measure, do not take this medicinal product for 30 minutes to 1 hour before or after taking other medicines.

Pregnancy and breast-feeding

Do not take this medicine if you are pregnant or breast-feeding.

Driving and using machines

No studies on the effect on the ability to drive and use machines have been performed.

Toussistop Cold Relief oral solution with food and drink

Avoid drinking for 30 minutes to 1 hour after taking this medicine.

Toussistop Cold Relief oral solution contains xylitol (E967)

This medicine contains 11.04 g xylitol (calorific value is 2.4 kcal/g xylitol, corresponding to 26.5 kcal) in the maximum daily dose (60 ml). It may have a laxative effect.

Toussistop Cold Relief oral solution contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216)

This medicine contains methyl parahydroxybenzoate and propyl parahydroxybenzoate. May cause hypersensitivity (allergic) reactions, possibly delayed.

Toussistop Cold Relief oral solution contains 13.6 mg of propylene glycol and 0.002 mg benzyl alcohol per 15 ml.

Benzyl alcohol may cause allergic reactions.

3. How to take Toussistop Cold Relief oral solution

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Start at the first sign of the common cold symptoms, such as chills, sore throat and cough.

Always use the enclosed measuring cup.

For oral use (undiluted).

The recommended dose is:

Adults, the elderly and children from 12 years and over:

Using the measuring cup provided, take 15 ml up to 4 times a day with a last dose taken at bedtime if required. Maximum daily dose 60 ml.

Do not give to children under 12 years old.

Do not take more medicine than the label tells you to.

If the symptoms worsen, or persist longer than 7 days during the use of the medicinal product, a doctor, pharmacist or a qualified health care practitioner should be consulted.

If you take more Toussistop Cold Relief oral solution than you should

Consult a doctor or contact your nearest hospital casulty department. Take this leaflet with you.

If you forget to take Toussistop Cold Relief oral solution

Do not take a double dose to make up for a forgotten dose. Take the next recommended dose when it is due.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine may cause side effects, although not everybody gets them.

There are no reported side effects for this medicine. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Reporting of side effects

You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Toussistop Cold Relief oral solution

Keep this medicine out of the sight and reach of children.

This medicinal product does not require any special storage conditions. Store in the original package.

After first opening the product, use within 2 months.

Do not use this medicine after the expiry date which is stated on the carton and on the bottle label. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Toussistop Cold Relief oral solution contains

  • The active substances are:

    Each 15 ml (= 16.3 g) dose of oral solution contains:

    187.5 mg of extract (as dry extract) from Althaea officinalis L., radix (Marshmallow root) (7- 9:1). Extraction solvent: water

    136.4 mg of extract (as dry extract) from Tilia cordata Miller, Tilia platyphyllos Scop., Tilia x vulgaris Heyne or their mixtures, flos (Lime flower) (3-8:1). Extraction solvent: water

    150.0 mg of extract (as dry extract) from Plantago lanceolata L., folium (Ribwort plantain) (4-6:1). Extraction solvent: water

  • The other ingredients are:

    • Maltodextrin
    • Silica colloidal anhydrous
    • Glycerol
    • Xylitol (E 967)
    • Methyl parahydroxybenzoate (E 218)
    • Propyl parahydroxybenzoate (E 216)
    • Citric acid monohydrate
    • Xanthan gum
    • Strawberry flavour (contains benzyl alcohol (E 1519) and propylene glycol (E 1520))
    • Water, purified

What Toussistop Cold Relief oral solution looks like and contents of the pack

Toussistop Cold Relief oral solution is a brown, opaque oral solution contained in a brown glass bottle with a nozzle and plastic screw cap packed in a carton box. It is provided with a plastic cup with a scale from 2.5 ml to 20 ml for measuring the recommended dose.

Toussistop Cold Relief oral solution is available in 120 ml, 200 ml and 240 ml pack sizes. Not all pack sizes may be marketed.

Traditional Herbal Registration Holder

Omega Pharma Limited, Wrafton, Braunton, Devon, EX33 2DL, UK

Manufacturer

Kwizda Pharma GmbH Effingergasse 21, 1160 Vienna, Austria

Distributed by Omega Pharma Ltd, Wrafton, Braunton, Devon, EX33 2DL, UK

Is this leaflet hard to see or read? Phone 01748 828860 for help.

This leaflet was last revised in 08/2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: THR028550339

Last revision stated in the text: August 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Toussistop Cold Relief oral solution

Marketing authorisation THR 02855/0339

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.